(Q38168996)

30 August 2017

Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage (English)

1 reference

30 August 2017

1 reference

1 reference

6

Marc Ladanyi

1 reference

30 August 2017

7

Jonathan I Epstein

1 reference

30 August 2017

9

Pedram Argani

1 reference

30 August 2017

Carla L Ellis

1

1 reference

30 August 2017

John N Eble

2

1 reference

30 August 2017

Andrea P Subhawong

3

1 reference

30 August 2017

Guido Martignoni

4

1 reference

30 August 2017

Minghao Zhong

5

1 reference

30 August 2017

George J Netto

8

1 reference

30 August 2017

6 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

27

1 reference

30 August 2017

6

1 reference

30 August 2017

875-886

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.208

30 August 2017

0 references

cites work

Xp11 translocation renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Renal cell carcinoma with translocation (X;1). Further evidence for a cytogenetically defined subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Translocation (X;1) associated with a nonpapillary carcinoma in a young woman: a new definition for an Xp11.2 RCC subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Molecular cytogenetics of t(X;1)(p11.2;q21) with complex rearrangements in a renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

High chromosomal copy number alterations in Xp11 translocation renal cell carcinomas detected by array comparative genomic hybridization are associated with aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Translocation renal cell carcinoma: lack of negative impact due to lymph node spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Diagnosis of Xp11 translocation renal cell carcinomas in adult patients under 50 years: interest and pitfalls of automated immunohistochemical detection of TFE3 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Response to sorafenib in a patient with metastatic xp11 translocation renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Genomic heterogeneity of translocation renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Translocation carcinomas of the kidney after chemotherapy in childhood

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Reviews on chromosome studies in urological tumors. I. Renal tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Cytogenetics of a renal adenocarcinoma in a 2-year-old child

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Translocation (X;1)(p11.2;q21) in a papillary renal cell carcinoma in a 14-year-old girl.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Molecular heterogeneity of TFE3 activation in renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Renal adenocarcinoma in an 8-year-old child, with a t(X;17)(p11.2;q25)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Renal-cell carcinoma in children: a different disorder from its adult counterpart?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Cytologic and cytogenetic diagnosis of pediatric renal cell carcinoma associated with t(X;17)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Pediatric renal cell carcinomas with Xp11.2 rearrangements are immunoreactive for hMLH1 and hMSH2 proteins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

Role of fusion subtype in Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinib

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.208

7 January 2021

10.1038/MODPATHOL.2013.208

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

0 references

1 reference